Andrew R. Robbins

2017

In 2017, Andrew R. Robbins earned a total compensation of $2.7M as Chief Operating Officer at Array BioPharma, a 135% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$218,671
Option Awards$1,588,246
Salary$435,036
Stock Awards$459,990
Other$38,215
Total$2,740,158

Robbins received $1.6M in option awards, accounting for 58% of the total pay in 2017.

Robbins also received $218.7K in non-equity incentive plan, $435K in salary, $460K in stock awards and $38.2K in other compensation.

Rankings

In 2017, Andrew R. Robbins' compensation ranked 4,014th out of 14,666 executives tracked by ExecPay. In other words, Robbins earned more than 72.6% of executives.

ClassificationRankingPercentile
All
4,014
out of 14,666
73rd
Division
Manufacturing
1,410
out of 5,770
76th
Major group
Chemicals And Allied Products
405
out of 2,074
81st
Industry group
Drugs
313
out of 1,730
82nd
Industry
Pharmaceutical Preparations
250
out of 1,329
81st
Source: SEC filing on September 13, 2017.

Robbins' colleagues

We found five more compensation records of executives who worked with Andrew R. Robbins at Array BioPharma in 2017.

2017

Ron Squarer

Array BioPharma

Chief Executive Officer

2017

Victor Sandor

Array BioPharma

Chief Medical Officer

2017

Jason Haddock

Array BioPharma

Chief Financial Officer

2017

John Moore

Array BioPharma

General Counsel

2017

David Horin

Array BioPharma

Chief Financial Officer

News

In-depth

You may also like